Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Deok-Hwan YangCheol Won Suh

Abstract

High-dose chemotherapy followed by autologous stem cell transplantation (HDT/ASCT) offers a rescue option for T cell lymphoma patients with poor prognosis. However, the effectiveness of HDT/ASCT in patients with various peripheral T cell subtypes, optimal transplant timing, and the prognostic factors that predict better outcomes, have not been identified. We retrospectively investigated the clinical outcomes and prognostic factors for HDT/ASCT in 64 Korean patients with peripheral T cell lymphoma, unspecified (PTCL-U) between March 1995 and February 2007. The median age at transplantation was 44 years (range: 15-63 years). According to the age-adjusted International Prognostic Index (a-IPI) and the prognostic index of PTCL (PIT), 8 patients (12.5%) were in the high-risk group and 16 (26.6%) had the 2-3 PIT factors, respectively. After a median follow-up of 29.7 months, the 3-year overall survival (OS) and progression-free survival (PFS) rates were 53.0% +/- 7.5% and 44.3% +/- 7.0%, respectively. Univariate analysis showed that poor performance status, high lactate dehydrogenase (LDH) levels, high a-IPI score, high PIT classes, failure to achieve complete response (CR) at transplantation, and nonfrontline transplantation were as...Continue Reading

References

Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J RodríguezE Conde
May 27, 2004·Leukemia & Lymphoma·Esa Jantunen, Francesco D'Amore
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paolo CorradiniCorrado Tarella
Sep 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K J SavageJ M Connors
Apr 22, 2005·British Journal of Haematology·Ruth SonnenNorbert Schmitz
Jun 9, 2006·British Journal of Haematology·Tarun KewalramaniCraig H Moskowitz
Jun 30, 2007·European Journal of Haematology·José RodríguezUNKNOWN 'Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea' (GEL-TAMO)
Jul 21, 2007·Haematologica·José RodríguezUNKNOWN Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea, Spanish Lymphoma/Autologous Bone Marrow Transplant Study Group
Dec 1, 2007·Hematological Oncology·Delvys Rodriguez-AbreuEmanuele Zucca
Mar 18, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mehdi HamadaniSteven M Devine
Apr 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven Le GouillUNKNOWN Société Française de Greffe de Moëlle et de Thérapie Cellulaire
Jun 11, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andy I ChenGinna G Laport

❮ Previous
Next ❯

Citations

Apr 29, 2010·Current Hematologic Malignancy Reports·Francesco d'AmoreThomas Relander
Jun 19, 2013·Best Practice & Research. Clinical Haematology·Andrei Shustov
May 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Hosing, R E Champlin
Sep 10, 2009·The Oncologist·Alison J Moskowitz, Craig H Moskowitz
Sep 3, 2013·Expert Review of Hematology·Giulia PerronePaolo Corradini
Apr 15, 2009·Expert Opinion on Pharmacotherapy·Mark PrichardJohn J Densmore
Sep 25, 2012·Expert Opinion on Drug Discovery·Georg HopfingerOlaf Merkel
Mar 26, 2014·Expert Opinion on Investigational Drugs·Alessandra DondiStefano Sacchi
Sep 12, 2014·Annals of Medicine·Mehdi Hamadani
Jan 29, 2014·Seminars in Hematology·Giulia PerronePaolo Corradini
Jan 29, 2014·Seminars in Hematology·Mehdi HamadaniMohamed A Kharfan-Dabaja
Oct 1, 2013·Critical Reviews in Oncology/hematology·Maria Gkotzamanidou, Christos A Papadimitriou
Apr 3, 2010·Seminars in Hematology·Pier Luigi Zinzani
Feb 6, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Amer BeitinjanehIssa F Khouri
Feb 23, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Auayporn NademaneeStephen J Forman
Dec 3, 2014·Journal of Clinical Epidemiology·George C M SiontisJohn P A Ioannidis
Apr 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P CorradiniS Tura
Feb 13, 2018·Bone Marrow Transplantation·Ya-Ting HsuTsai-Yun Chen
Nov 21, 2012·Oncology Reports·Noriyoshi IriyamaJin Takeuchi
Oct 30, 2020·Cancers·Chathuri AbeyakoonH Miles Prince

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
S MercadalGrup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Auayporn NademaneeStephen J Forman
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Andy I ChenGinna G Laport
© 2021 Meta ULC. All rights reserved